Compound ID | 1441

TP-2758

Class: Tetracycline

Spectrum of activity: Gram-negative
Details of activity: Useful against Tetracycline resistant Enterobacteriacae
Institute where first reported: Tetraphase (Watertown, MA, USA)
Year first mentioned: 2011
Highest developmental phase: Phase 1 (Eudract number 2011-001204-35)
Development status: Discontinued
Reason Dropped: Results unavailable (removed from company pipeline; Tetraphase was alter acquired by La Jolla Pharmaceutical Company in 2020)
Chemical structure(s):
Click here for structure editor
Molecular weight: 541.59
Iso. SMILES: CCN1CCC[C@H]1C2=CC(=C3C(=C2OC)C[C@H]4C[C@H]5[C@@H](C(=O)C(=C([C@]5(C(=O)C4=C3O)O)O)C(=O)N)N(C)C)O
InChI Key: KVWRAGSRFSMWMO-MEKZYAFBSA-N
Can. SMILES: CCN1CCC[C@H]1C2=CC(=C3C(=C2OC)C[C@H]4C[C@H]5[C@@H](C(=O)C(=C([C@]5(C(=O)C4=C3O)O)O)C(=O)N)N(C)C)O
InChI: InChI=1S/C28H35N3O8/c1-5-31-8-6-7-16(31)13-11-17(32)19-14(24(13)39-4)9-12-10-15-21(30(2)3)23(34)20(27(29)37)26(36)28(15,38)25(35)18(12)22(19)33/h11-12,15-16,21,32-33,36,38H,5-10H2,1-4H3,(H2,29,37)/t12-,15-,16-,21-,28-/m0/s1

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.